- Investing Ideas
- /
- Telecom Healthcare Sector
Telecom Healthcare Sector
Results
2301
All the companies in the healthcare sector, including healthcare provider and equipment, healthcare tech, pharmaceuticals, biotech and life sciences.
2301 companies
Nutex Health
Market Cap: US$918.6m
Operates as a physician-led, healthcare services, and operations company in the United States.
NUTX
US$165.42
7D
2.2%
1Y
2,380.1%
Wave Life Sciences
Market Cap: US$915.6m
A clinical-stage biotechnology company, designs, develops, and commercializes ribonucleic acid (RNA) medicines through PRISM, a discovery and drug development platform.
WVE
US$6.05
7D
0.2%
1Y
0.8%
Spyre Therapeutics
Market Cap: US$910.1m
A clinical stage biotechnology company, focuses on developing therapeutics for patients living with inflammatory bowel disease (IBD).
SYRE
US$15.55
7D
3.2%
1Y
-54.3%
InMode
Market Cap: US$909.6m
Designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radio frequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States, Europe, Asia, and internationally.
INMD
US$14.59
7D
1.8%
1Y
-22.7%
Extendicare
Market Cap: CA$1.2b
Through its subsidiaries, provides care and services for seniors in Canada.
EXE
CA$14.42
7D
1.2%
1Y
94.9%
Evolent Health
Market Cap: US$885.2m
Through its subsidiary, provides specialty care management services in oncology, cardiology, and musculoskeletal markets in the United States.
EVH
US$7.37
7D
0.1%
1Y
-65.8%
Avadel Pharmaceuticals
Market Cap: US$876.5m
Operates as a biopharmaceutical company in the United States.
AVDL
US$9.05
7D
-1.1%
1Y
-41.9%
Syndax Pharmaceuticals
Market Cap: US$870.8m
A commercial-stage biopharmaceutical company, develops therapies for the treatment of cancer.
SNDX
US$10.63
7D
-1.7%
1Y
-44.9%
Niagen Bioscience
Market Cap: US$866.7m
Operates as a bioscience company engages in developing healthy aging products.
NAGE
US$10.82
7D
6.5%
1Y
282.3%
Nanosonics
Market Cap: AU$1.3b
Operates as an infection prevention company globally.
NAN
AU$4.40
7D
-1.3%
1Y
61.8%
HealthStream
Market Cap: US$856.5m
Provides Software-as-a-Service (SaaS) based applications for healthcare organizations in the United States.
HSTM
US$27.89
7D
0.3%
1Y
2.7%
Gyre Therapeutics
Market Cap: US$852.7m
A pharmaceutical company, engages in the development and commercialization of small-molecule, anti-inflammatory, and anti-fibrotic drugs targeting organ fibrosis.
GYRE
US$9.46
7D
-15.6%
1Y
-9.1%
CorMedix
Market Cap: US$849.8m
A biopharmaceutical company, focuses on developing and commercializing therapeutic products for life-threatening diseases and conditions in the United States.
CRMD
US$12.43
7D
1.1%
1Y
136.8%
Pharvaris
Market Cap: US$842.5m
A late-stage biopharmaceutical company, focuses on the development and commercialization of therapies for rare diseases with unmet needs covering angioedema and other bradykinin-mediated diseases.
PHVS
US$16.72
7D
2.0%
1Y
-11.5%
uniQure
Market Cap: US$823.4m
Develops treatments for patients suffering from rare and other devastating diseases in the United States.
QURE
US$14.90
7D
-2.2%
1Y
218.4%
AMN Healthcare Services
Market Cap: US$809.7m
Provides technology-enabled healthcare workforce solutions and staffing services to acute and sub-acute care hospitals, and other healthcare facilities in the United States.
AMN
US$21.09
7D
-2.7%
1Y
-61.2%
LENZ Therapeutics
Market Cap: US$808.1m
Operates as a biopharmaceutical company that focuses on the development and commercialization of therapies to improve vision in the United States.
LENZ
US$29.53
7D
4.6%
1Y
90.4%
SI-BONE
Market Cap: US$792.2m
A medical device company, focuses on solving musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally.
SIBN
US$18.49
7D
-3.3%
1Y
36.7%
Enliven Therapeutics
Market Cap: US$788.5m
A clinical-stage biopharmaceutical company, focuses on the discovery and development of small molecule inhibitors to help patients with cancer.
ELVN
US$17.74
7D
5.8%
1Y
-21.3%
Zymeworks
Market Cap: US$782.5m
A clinical-stage biotechnology company, discovers, develops, and commercializes biotherapeutics for the treatment of cancer, and autoimmune and inflammatory diseases (AIID).
ZYME
US$11.35
7D
-1.1%
1Y
34.6%
Cronos Group
Market Cap: CA$1.1b
A cannabinoid company, engages in the cultivation, production, distribution, and marketing of cannabis products in Canada, Israel, and internationally.
CRON
CA$2.83
7D
-1.0%
1Y
-17.3%
Xeris Biopharma Holdings
Market Cap: US$765.5m
A commercial-stage biopharmaceutical company, engages in developing and commercializing therapies for chronic endocrine and neurological diseases in Illinois.
XERS
US$5.04
7D
3.3%
1Y
127.0%
Akebia Therapeutics
Market Cap: US$756.4m
A biopharmaceutical company, focuses on the development and commercialization of therapeutics for patients with kidney diseases.
AKBA
US$3.01
7D
6.4%
1Y
178.7%
Praxis Precision Medicines
Market Cap: US$754.3m
A clinical-stage biopharmaceutical company, engages in the development of therapies for central nervous system (CNS) disorders characterized by neuronal excitation-inhibition imbalance.
PRAX
US$38.45
7D
0.4%
1Y
-15.5%
Immunome
Market Cap: US$750.9m
A clinical-stage biotechnology company, develops targeted cancer therapies.
IMNM
US$8.95
7D
5.8%
1Y
-39.2%
Nuvation Bio
Market Cap: US$748.6m
A clinical-stage biopharmaceutical company, focuses on developing therapeutic candidates for oncology.
NUVB
US$2.26
7D
0.4%
1Y
-24.4%
WELL Health Technologies
Market Cap: CA$1.0b
Operates as a practitioner-focused digital healthcare company in Canada, the United States, and internationally.
WELL
CA$4.09
7D
0%
1Y
11.1%
Nurix Therapeutics
Market Cap: US$744.8m
A clinical stage biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule and antibody therapies for the treatment of cancer, inflammatory conditions, and other diseases.
NRIX
US$10.04
7D
2.7%
1Y
-33.6%
GH Research
Market Cap: US$725.7m
Together with its subsidiary, a clinical-stage biopharmaceutical company, engages in developing treatments for depression in the United States.
GHRS
US$12.57
7D
6.6%
1Y
-2.8%
Veradigm
Market Cap: US$721.8m
A healthcare technology company, provides information technology solutions to healthcare providers, payers, and biopharma markets in the United States and internationally.
MDRX
US$4.20
7D
-4.5%
1Y
-57.0%
ArriVent BioPharma
Market Cap: US$705.8m
A clinical-stage biopharmaceutical company, engages in the identification, development, and commercialization of medicines for the unmet medical needs of patients with cancers.
AVBP
US$20.04
7D
-2.1%
1Y
6.7%
Curaleaf Holdings
Market Cap: CA$923.9m
Produces and distributes cannabis products in the United States and internationally.
CURA
CA$1.22
7D
1.7%
1Y
-80.4%
IRADIMED
Market Cap: US$668.2m
Develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible medical devices and related accessories, and disposables and services in the United States and internationally.
IRMD
US$51.66
7D
-2.9%
1Y
22.4%
Nika Pharmaceuticals
Market Cap: US$667.0m
A pharmaceutical company, develops drugs for the treatment of HIV/AIDS, hepatitis B and C, rheumatoid arthritis, cancer, diabetes, and various other diseases.
NIKA
US$0.65
7D
-0.9%
1Y
n/a
Vir Biotechnology
Market Cap: US$658.0m
A clinical-stage biopharmaceutical company, discovers and develops therapeutic products to treat and prevent serious infectious diseases in the United States and internationally.
VIR
US$5.19
7D
12.6%
1Y
-50.0%
Arbutus Biopharma
Market Cap: US$653.1m
A clinical-stage biopharmaceutical company, develops novel therapeutics for infectious disease in the United States.
ABUS
US$3.44
7D
6.8%
1Y
3.6%